Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of ITeos Therapeutics Inc (NASDAQ: ITOS) closed at $10.2 in the last session, down -0.10% from day before closing price of $10.21. In other words, the price has decreased by -$0.10 from its previous closing price. On the day, 0.72 million shares were traded. ITOS stock price reached its highest trading level at $10.2 during the session, while it also had its lowest trading level at $10.15.
Ratios:
We take a closer look at ITOS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.53 and its Current Ratio is at 7.53. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On May 28, 2025, Wedbush Downgraded its rating to Neutral which previously was Outperform but kept the price unchanged to $12.
Leerink Partners Downgraded its Outperform to Market Perform on May 14, 2025, while the target price for the stock was maintained at $9.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 09 ’25 when Detheux Michel sold 43,882 shares for $10.03 per share. The transaction valued at 440,136 led to the insider holds 0 shares of the business.
Detheux Michel sold 43,883 shares of ITOS for $439,708 on Jun 10 ’25. The Chief Executive Officer now owns 0 shares after completing the transaction at $10.02 per share. On Jun 09 ’25, another insider, Detheux Michel, who serves as the Chief Executive Officer of the company, sold 8,400 shares for $10.03 each. As a result, the insider received 84,252 and left with 135,903 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ITOS now has a Market Capitalization of 450895072 and an Enterprise Value of -59406940.
Stock Price History:
The Beta on a monthly basis for ITOS is 1.31, which has changed by -0.41647595 over the last 52 weeks, in comparison to a change of 0.13054323 over the same period for the S&P500. Over the past 52 weeks, ITOS has reached a high of $18.13, while it has fallen to a 52-week low of $4.80. The 50-Day Moving Average of the stock is 0.76%, while the 200-Day Moving Average is calculated to be 23.48%.
Shares Statistics:
According to the various share statistics, ITOS traded on average about 1.43M shares per day over the past 3-months and 995560 shares per day over the past 10 days. A total of 44.17M shares are outstanding, with a floating share count of 42.71M. Insiders hold about 3.37% of the company’s shares, while institutions hold 93.69% stake in the company. Shares short for ITOS as of 1753920000 were 2967013 with a Short Ratio of 2.08, compared to 1751241600 on 2832859. Therefore, it implies a Short% of Shares Outstanding of 2967013 and a Short% of Float of 8.32.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The firm’s stock currently is rated by 1.0 analysts. The consensus estimate for the next quarter is -$0.22, with high estimates of -$0.22 and low estimates of -$0.22.
Analysts are recommending an EPS of between -$3.84 and -$3.84 for the fiscal current year, implying an average EPS of -$3.84. EPS for the following year is -$2.68, with 2.0 analysts recommending between -$1.85 and -$3.52.
